April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 26, 2025

HER2-Selective TKI in Advanced Solid Tumors with HER2 Alterations

In a phase Ia/Ib study (Beamion LUNG-1) reported in the Journal of Clinical Oncology, Heymach et al evaluated the safety profile and activity of zongertinib in patients with HER2-altered solid tumors....

The ASCO Post

March 26, 2025

State Eyes New Tools to Bolster Health Workforce

Proposals include licensure for community health workers, expanded provider roles, and Medicaid coverage adjustments to address staffing gaps and access barriers.

KFF Health News

March 25, 2025

Most Pediatric Valve Implants Used Off-Label

Fewer than 10% of cardiac valve devices implanted in U.S. pediatric patients were FDA approved for children.

Conexiant

March 24, 2025

Sex Differences in Asthma and COPD Hospital Admission Outcomes: Study

Females with asthma had 'higher odds of readmission within 30 and 90 days' compared with males, according to a new study on sex differences in asthma and COPD outcomes.

Conexiant

March 21, 2025

Vutrisiran Receives FDA Nod for ATTR Amyloidosis With Cardiomyopathy

The FDA approves vutrisiran (Amvuttra) as the first RNAi therapeutic to reduce cardiovascular events and mortality in adults with transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

Conexiant

March 20, 2025

Study Links Time to Lung Test Results

The odds of a positive bronchodilator response decrease by 8% per hour during the workday, researchers report in the SPIROTIMETRY study.

Conexiant

March 19, 2025

Awake Prone Positioning May Reduce COVID-19 Intubation

Researchers found that awake prone positioning was associated with improved survival without intubation and reduced mortality in patients with COVID-19 and acute hypoxemic respiratory failure.

Conexiant